PROBLEMS AND PERSPECTIVES OF ANTIBACTERIAL THERAPY OF CHRONIC PSEUDOMONAS INFECTION IN PATIENTS WITH CYSTIC FIBROSIS

<p><em>Authors analyze the data on effectiveness and safety of new regimen of combined antibacterial therapy with solution of tobramycin for inhalations 300 mg/5 ml (Tobi). This drug was administered to 23 patients with cystic fibrosis during 15 days at the time of an exacerbation. It wa...

Full description

Bibliographic Details
Main Authors: S.Yu. Semykin, S.S. Postnikov, S.V. Polikarpova, L.G. Dubovik, M.A. Sagatelyan
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2010-01-01
Series:Вопросы современной педиатрии
Online Access:http://vsp.spr-journal.ru:80/jour/article/view/866
Description
Summary:<p><em>Authors analyze the data on effectiveness and safety of new regimen of combined antibacterial therapy with solution of tobramycin for inhalations 300 mg/5 ml (Tobi). This drug was administered to 23 patients with cystic fibrosis during 15 days at the time of an exacerbation. It was shown that addition of inhaled solution of tobramycin to the antibiotics increased clinical and bacteriological effectiveness of treatment of bronchopulmonary process.</em><strong><em></em></strong></p><p><strong><em>Key words: children, chronic Pseudomonal infection, tobramycin for inhalations.</em></strong><br /><span style="text-decoration: underline;"><em>(<em><em>Voprosy sovremennoi pediatrii — </em></em>Current Pediatrics. 2010;9(2):<em>94-98</em>)</em></span></p>
ISSN:1682-5527
1682-5535